1-3 of 3
Michal Bar-Natan, M.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets

Sophia Adamia, Ph.D, Michal Bar-Natan, M.D, Benjamin Haibe-Kains, Ph.D, HerveĢ Avet-Loiseau, MD, PhD, Laurence Lode, Ph.D, Samuel Pevzner, Sigitas Verselis, PhD, Edward Fox, PhD, Ilene Galinsky, ANP, John Quackenbush, Ph.D, Richard M. Stone, MD, James D Griffin, MD
Journal: Blood
Blood (2011) 118 (21): 761.
https://doi.org/10.1182/blood.V118.21.761.761
Published: 2011
Journal Articles

Identification of Novel Splice Variants of Multiple Genes Using Genome-Wide Analysis of Alternative Splicing in Patients with Acute Myeloid Leukemia.

Sophia Adamia, Michal Bar-Natan, M.D, Richard Stone, MD, James D Griffin
Journal: Blood
Blood (2009) 114 (22): 1278.
https://doi.org/10.1182/blood.V114.22.1278.1278
Published: 2009
Journal Articles

Inhibition of Both Jak2 and STAT5 Enhances Toxicity to Myeloproliferative Cells.

Michal Bar-Natan, M.D, Erik A. Nelson, PhD, Sarah R. Walker, Ph.D., Rosemary Barrett, B.S., David A. Frank, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1905.
https://doi.org/10.1182/blood.V114.22.1905.1905
Published: 2009